Laboratorios Farma | ROVI - Debt

Stock Price
79.25
Daily Change
-1.45 -1.80%
Monthly
-0.69%
Yearly
54.18%
Q2 Forecast
79.04

Laboratorios Farma reported EUR129.3M in Debt for its fiscal semester ending in June of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Almirall EUR 342.86M 61.94M Dec/2025
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Ionis Pharmaceuticals USD 2.33B 1.1B Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Pharma Mar EUR 49.42M 1.98M Dec/2025
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.41B 25.6M Dec/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025